In a very real and practical way, using one testing method can result in a different legal outcome than a using a different method.
“The evolving regulatory status of CBD”, a paper I co-wrote with Dr. Jamie Corroon, was published this week on the popular Project CBD website.
I enjoyed sharing a panel to discuss hemp legal issues with my friends and fellow attorneys at the Southern US Hemp Conference and Expo this week in Myrtle Beach, South Carolina.
Growing hemp in the US will be different next year, whether or not Congress finally gets its act together and passes the 2018 Farm Bill with its new hemp provisions.
Research suggests that some cannabinoids may, in fact, increase focus, suppress appetite and keep users awake.
To say that all CBD is unlawful because it is a derivative of Cannabis is nonsensical; there are lawful and unlawful types of Cannabis.
The “Regulatory Status of Cannabidiol in the United States: A Perspective”, an article I co-wrote with Dr. Jamie Corroon, was published this week in Cannabis and Cannabinoid Research, a peer reviewed journal.
Canada is clearly leading the way on global cannabis reform; the question remains will the United States follow suit quickly enough to capitalize on this nascent market before Canada asserts its dominance as a global provider of quality hemp and marijuana products?
We can expect a bumpy ride until the 2018 Farm Bill is passed. So, buckle in and hold on for the next few months. Change is coming.
The Ohio Board of Pharmacy issued two Guidance Documents regarding CBD this week that have caused an uproar. Is the Pharmacy Board right?